Researchers analyzed fusion status for 252 patients who had interbody fusion with CBA. After 12 months overall fusion success rates were 98.1% with the anterior approach, 100% for the lateral approach and 97.9% for the posterior approach. After two years the overall fusion success rate for fusion success was 97.9%, 100.0%, and 98.8% for anterior, lateral, and posterior approaches, respectively.
The study concluded, “CBA represents an attractive alternative to autograft alone, reporting a high rate of successful fusion and clinical outcomes across various surgical approaches.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
